US Venture Partners — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
HealthtechMountain View, US
Charles Taylor(Director)John Farquhar(Executive Officer, Director)Vikram Verghese(Executive Officer)Monica Tellado(Executive Officer)
BoardJeff Lightcap(Director)
Board seatCasey Tansey· per SEC Form D · $50M raise · filed Apr 2025
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment.
Digital HealthHealthtechMedical DevicesAustin, US
Richard John Foust(Executive Officer, Director)Frank McEachern(Executive Officer, Director)
BoardNelson Bunker Curnes(Executive Officer, Director)Thomas Jordan Curnes II(Executive Officer, Director)Dana Mead(Director)
Board seatCasey Tansey· per SEC Form D · $65M raise · filed Mar 2025
Co-investorsLongitude CapitalUT Horizon Fund
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.
HardwareHealthtechMedical DevicesNorthern California, US
Robert Ball(CEO & Executive Chairman)Matthew Ahearn(Chief Operating Officer)Jeff Points(Executive Officer)David Blue(Executive Officer)Don Running(Manager and Chief Executive Officer)Jeff Ondrla(Chief Technology Officer)
Board seatCasey Tansey· per SEC Form D
Co-investorsAPERTURE Venture PartnersArboretum VenturesGenesis Innovation GroupGlobal BrainInvest MichiganLightstone Ventures+2 more
HealthtechSan Francisco, US
Senan Ebrahim(Executive Officer, Director)Isabel Fulcher(Director)
BoardJacob Yormak(Director)
Board seatDafina Toncheva· per SEC Form D · $17.4M raise · filed Feb 2025
Co-investorsBoutique Venture PartnersArtis VenturesBread And Butter Ventures, LlcBread Butter VenturesGoodwater CapitalMetrodora Ventures+3 more
Iantrek develops micro-interventional surgical technology using allogeneic biotissue to create a category it calls Bio-intervention for treating chronic eye disease.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))Michael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Board seatCasey Tansey· per SEC Form D
Co-investorsaMoonVisionary VenturesCanaan PartnersCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLC
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation.
Advanced ManufacturingHealthtechMedical DevicesMaple Grove, US
Todd Berg(Executive Officer, Director)David H. Chung(Executive Officer, Director)Ron Nelson(Executive Officer)
BoardMudit K. Jain(Director)Andrew ElBardissi(Director)in
Board seatCasey Tansey· per SEC Form D
Co-investorsTreo Ventures, LlcDeerfield Management Company
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.